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Brucellosis is primarily a disease of animals (zoonosis), but it can be transferred to humans by ingestion of infected/contaminated dairy products [1]. Brucellosis is still a very 
important public health problem in many countries including 
Mediterranean areas, parts of South and Central America, Africa, 
and India [2]. Brucella melitensis is possibly the most virulent 
species to cause human infections all over the world including 
India, followed by Brucella abortus and Brucella suis [3,4]. Human 
brucellosis develops following consumption of unpasteurized, 
contaminated milk or soft cheese infected with B. melitensis [5]. 
Brucellosis was once thought to be an uncommon or mild disease 
in children but now recognized as an underdiagnosed disease 
among persons of all ages [1]. It is characterized by myriad of 
non-specific symptoms along with complications [6]. Being a 
multisystem disease with protean presentations, brucellosis can 
often present as a diagnostic dilemma for clinicians [7]. Here, we 
discuss a 5-year child, with varied presentations at onset, finally 
diagnosed to have brucellosis.
CASE REPORT
A 5-year boy was referred to the outpatient department of 
our tertiary care hospital in Northern India. The child had 
fever without localization for the past 5 months, which 
was high grade, remittent, and not associated with chills or 
rigors. He also had weight loss of 5 kg over the past 5 months 
coupled with mild occasional cough. Due to the illness, he 
had frequent school absenteeism for the past 5 months. He 
did not have a history of rash, arthralgia, night sweats, or 
contact to a proven case of tuberculosis. His father was 
a truck driver by occupation, and there was a history of 
exposure to farm animals, although consumption of raw milk 
was denied. There was no similar family history in any of the 
family members.
On physical examination, boy had non-significant, non-
tender, generalized lymphadenopathy, mild pallor, firm non-
tender hepatomegaly of 5 cm below the right costal margin, 
and splenomegaly of 3.5 cm below the left costal margin. 
Respiratory system, cardiovascular system, and central 
nervous system examinations were normal. For fever, he was 
treated twice with intravenous third-generation cephalosporin 
and oral azithromycin, each lasting 7–10 days, considering it 
a case of typhoid fever by local physicians, without clinical 
response. Laboratory investigations revealed Hb – 9.4 mg/dl, 
total leukocyte count 9800/mm3 (45% lymphocytes), platelet 
count 320,000/µL, and normal peripheral smear and 
erythrocyte sedimentation rate of 54 mm/hr. Biochemical 
parameters were normal. HIV serology, tubercular workup, 
Widal test, and ANA test were negative. Chest X-ray was 
non-contributory.
Brucella standard agglutination test (SAT) showed a titer 
of 2560 IU which decreased to 1298 IU on treatment with 
0.05 M 2-mercapto-ethanol (2ME) showing that it was a recent 
infection. 5-day blood culture in automated BACTEC 9240 
(BD Diagnostics, USA) system was sterile, but prolonged 
incubation showed the growth of Brucella species, which 
was identified by non-motile, non-capsulated Gram-negative 
coccobacilli. It gave positive reaction with oxidase, catalase, 
and urease test and produced acid from xylose in oxidative-
fermentative medium [8]. On antimicrobial susceptibility 
testing, it was sensitive to cotrimoxazole, erythromycin, 
chloramphenicol, ciprofloxacin, and rifampicin. On the basis 
of these laboratory reports, diagnosis of brucellosis was 
confirmed.
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He was treated with rifampicin at 15 mg/kg/day 
and trimethoprim-sulfamethoxazole (TMP-SMZ) TMP 
at 10 mg/kg/day and SMZ at 50 mg/kg/day for 6 weeks. The 
intensity of fever started decreasing after 1 week, subsiding 
after 2 weeks of therapy. At follow-up after 8 weeks, 
hepatomegaly and splenomegaly also reduced. Child gained 
weight and did not have recurrence of disease at 9 months of 
follow-up.
DISCUSSION
In India, brucellosis is predominantly an occupational 
disease occurring among farmers, veterinarians, and abattoir 
workers [3]. Although brucellosis comes under differential 
diagnosis of any algorithm of pyrexia of unknown origin, yet the 
true incidence of human brucellosis is unknown. Seroprevalence 
studies suggest that human Brucella infection may range 
between 0.9% and 18.1% among veterinarians and farm 
attendees. Prolonged fever is usually the most common clinical 
manifestation of brucellosis, followed by other features such 
as arthralgia, hepatosplenomegaly, weight loss, malaise, and 
poor appetite [9]. Literature mentioned arthralgia in 50–60% of 
children while arthritis is less commonly seen [10]. Our patient 
had fever, dry cough, and weight loss with hepatosplenomegaly 
but no arthralgia or arthritis. Only 16% of children are reported 
to have present with non-tender, discrete lymphadenopathy [9]. 
Other less common presentations include vasculitis, deep vein 
thrombosis, nephritis, and meningitis. Ocular manifestations 
are seen rarely in the form of optic neuritis, uveitis, and 
papilledema [11]. Common hematologic findings seen are 
anemia, leukopenia, and thrombocytopenia [12].
Brucellosis rarely figures in the differential diagnosis of a 
long-standing fever and most of the time child is investigated 
for enteric fever and tuberculosis [6]. In endemic countries, 
brucellosis may also be unknowingly treated by rifampicin 
presumptively started for tuberculosis. Hence, brucellosis should 
be considered as one of the differential diagnoses of prolonged 
fever in children. Blood culture remains the gold standard for 
diagnosis, which is usually positive between 7 and 21 days but 
may take up to 6 weeks by the conventional method though 
using the automated system, majority of the isolates grow 
in 3–5 days [13]. Blood cultures are positive only in 17–50% 
of cases of brucellosis; bone marrow cultures have the higher 
yield and can be used in chronic cases. In addition to blood 
culture, serology for specific antibody detection is an alternative 
tool for early diagnosis; standard tube agglutination (SAT) is 
the most widely used method. SAT detects both IgM and IgG 
antibodies against Brucella, and titers >1:160 are suggestive of 
acute infection. IgG quantification can be done by the treatment 
of serum with 2-ME, which is more useful after treatment to 
follow response. Although enzyme-linked immunosorbent assay 
(ELISA), rose Bengal plate agglutination test, Coombs test, 
immune-capture agglutination test, latex agglutination test, and 
lateral flow assays have been used for this purpose. ELISA can 
detect IgM and IgG separately so can be used to differentiate 
between acute and chronic phases of brucellosis. Sensitivity of 
ELISA has been found to be lower (80% IgM and 50% IgG) 
than that of SAT (95%). Polymerase chain reaction assays have 
been developed and are found to have superior specificity and 
sensitivity in detecting both primary infection and relapse after 
treatment [14].
Treatment of brucellosis mainly consists of various 
combinations of drugs such as tetracyclines, streptomycin, 
rifampicin, and cotrimoxazole (TMP-SMX). Treatment is aimed 
mainly at treating current infection and prevention of subsequent 
relapses. Various treatment regimens described include 
streptomycin with doxycycline, rifampicin with doxycycline, 
and TMP-SMX with streptomycin or rifampicin (in patients 
where tetracyclines are avoided). Usual treatment duration 
is for 6 weeks. However, prolonged therapy is indicated in 
neurobrucellosis (usually 3–6 months). With these combination 
of drugs, response rate is very good with less chance of future 
relapse [15,16]. Relapses are usually seen after monotherapy 
with rifampicin or streptomycin or when compliance is poor. 
Most relapses are seen within 6 months of discontinuation of 
therapy.
CONCLUSIONS
Brucellosis should be considered as one of the differential 
diagnoses of prolonged fever in children. Timely and accurate 
diagnosis of brucellosis is challenging due to non-specific clinical 
features and slow growth rate in blood culture.
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